Detalles de la búsqueda
1.
Tumor residue in patients with stage II-IVA nasopharyngeal carcinoma who received intensity-modulated radiation therapy: development and validation of a prediction nomogram integrating postradiotherapy plasma Epstein-Barr virus deoxyribonucleic acid, clinical stage, and radiotherapy dose.
BMC Cancer
; 23(1): 410, 2023 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37149594
2.
Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trial.
Lancet Oncol
; 22(5): 716-726, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33857411
3.
Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial.
Lancet Oncol
; 19(4): 461-473, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29501366
4.
Safety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trial.
BMC Cancer
; 17(1): 134, 2017 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28202000
5.
Positive effect of HPV status on prognostic value of blood lymphocyte-to-monocyte ratio in advanced cervical carcinoma.
Cancer Cell Int
; 16: 54, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27382361
6.
Elevated peripheral blood lymphocyte-to-monocyte ratio predicts a favorable prognosis in the patients with metastatic nasopharyngeal carcinoma.
Chin J Cancer
; 34(6): 237-46, 2015 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-26067059
7.
Toripalimab plus capecitabine in the treatment of patients with residual nasopharyngeal carcinoma: a single-arm phase 2 trial.
Nat Commun
; 15(1): 949, 2024 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38297016
8.
Camrelizumab and apatinib plus induction chemotherapy and concurrent chemoradiotherapy in stage N3 nasopharyngeal carcinoma: a phase 2 clinical trial.
Nat Commun
; 15(1): 1029, 2024 Feb 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38310101
9.
Favorable prognosis of female patients with nasopharyngeal carcinoma.
Chin J Cancer
; 32(5): 283-8, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22980419
10.
Development of a prognostic model to identify the metastatic nasopharyngeal carcinoma patients who may benefit from chemotherapy combination PD-1 inhibitor.
Front Immunol
; 14: 1069010, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36733479
11.
Effective of metastasis-directed therapy for de novo metastatic nasopharyngeal carcinoma: A propensity score matched analysis.
Head Neck
; 45(10): 2571-2579, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37554098
12.
Efficacy and safety of sintilimab plus bevacizumab in metastatic nasopharyngeal carcinoma after failure of platinum-based chemotherapy: an open-label phase 2 study.
EClinicalMedicine
; 62: 102136, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37593221
13.
A deep learning-based semiautomated workflow for triaging follow-up MR scans in treated nasopharyngeal carcinoma.
iScience
; 26(12): 108347, 2023 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38125021
14.
Plasma Circulating Tumor Epstein-Barr Virus for the Surveillance of Cancer Progression in Bone-Only Metastatic Nasopharyngeal Carcinoma.
Front Oncol
; 12: 860700, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35756638
15.
Effect of Capecitabine Maintenance Therapy Plus Best Supportive Care vs Best Supportive Care Alone on Progression-Free Survival Among Patients With Newly Diagnosed Metastatic Nasopharyngeal Carcinoma Who Had Received Induction Chemotherapy: A Phase 3 Randomized Clinical Trial.
JAMA Oncol
; 8(4): 553-561, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35175316
16.
Adjuvant Capecitabine Following Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Randomized Clinical Trial.
JAMA Oncol
; 2022 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36227615
17.
Effect of Induction Chemotherapy With Paclitaxel, Cisplatin, and Capecitabine vs Cisplatin and Fluorouracil on Failure-Free Survival for Patients With Stage IVA to IVB Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical Trial.
JAMA Oncol
; 8(5): 706-714, 2022 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35323856
18.
[Nedaplatin or cisplatin combined with 5-fluorouracil for treatment of stage III-IVa nasopharyngeal carcinoma: a randomized controlled study].
Zhonghua Zhong Liu Za Zhi
; 33(1): 50-2, 2011 Jan.
Artículo
en Zh
| MEDLINE | ID: mdl-21575465
19.
Prognostic and Predictive Value of Circulating Inflammation Signature in Non-Metastatic Nasopharyngeal Carcinoma: Potential Role for Individualized Induction Chemotherapy.
J Inflamm Res
; 14: 2225-2237, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34079329
20.
Trajectories of EBV DNA and identifying the potential long-term survivors in metastatic nasopharyngeal carcinoma.
Am J Cancer Res
; 11(8): 3946-3955, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34522460